Study guide
16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery
Key Takeaways Explain This Topic AI
Rx Summ–Surg 2023 [1291] uses 4-character codes for 2023+ diagnoses; codes start with A, except skin, colon, pancreas, lung, breast and thyroid, which use B-prefixed codes to signal a significant coding change.
Surgery codes record the most invasive, cumulative procedure: a lumpectomy followed by a total mastectomy is coded as the mastectomy, and an excisional biopsy that removes the whole tumor or leaves only microscopic margins is surgery, not a diagnostic procedure.
Special codes: A000/B000 none (also for autopsy diagnosis), A980 for sites such as C420–C424, C760–C768 and C809, A900/B900 surgery NOS, and A990/B990 unknown or death certificate only.
Scope of Regional LN Surgery [1292] is hierarchical and cumulative (0–7, 9): a sentinel biopsy followed later by a dissection is 7; the operative report, not the node count, distinguishes sentinel biopsy from dissection.
Surgical Margins [1320] codes 0–3 are hierarchical (0 none, 1 residual NOS, 2 microscopic, 3 macroscopic), 7 is not evaluable, 8 is no primary site surgery, and 9 is unknown.
Last updated: September 2026
How the surgery items fit together
Item Records
Rx Summ–Surg 2023 [1291] Most invasive surgery of the primary site , including tissue removed in continuity (at any facility)
Rx Hosp–Surg 2023 [671] The same item, limited to surgery at the reporting facility
Scope of Regional Lymph Node Surgery [1292] Removal, biopsy or aspiration of regional nodes (sentinel or dissection)
Surgical Procedure/Other Site [1294] Resection of distant nodes, or of regional or distant tissue or organs beyond the primary site range
- Surgical Margins of the Primary Site [1320] Final margin status after primary site surgery
- Reason for No Surgery of Primary Site [1340] Why primary site surgery was not done
- Date of First Surgical Procedure [1200] First of 1291, 1292 (excluding code 1) or 1294
- Date of Most Definitive Surgical Resection [3170] Date of the most definitive primary site surgery
- Readmission Within 30 Days of Surgical Discharge [3190] Quality item for unplanned readmission
If multiple primaries are treated in one operation, code the surgery items separately for each primary. Incidental removal of an organ (for example, an appendix during a right colectomy, or a gallbladder removed for another reason) does not change the codes.
Rx Summ–Surg 2023 [1291]
Diagnosis years: this item is used for 2023+ . Earlier cases use Surgical Procedure of Primary Site [1290], and 1291 is left blank.
Prefix: codes begin with A , except skin, colon, pancreas, lung, breast and thyroid , which use B codes to mark a significant change in coding. The site-specific codes are in Appendix A .
- Code range Meaning
- A000 / B000 None; also used when the cancer was diagnosed at autopsy
- A100–A190 / B100–B190 Tumor destruction , with no pathology specimen (for example, ablation)
- A200–A800 / B200–B800 Resection procedures, from local excision to radical surgery
- A900 / B900 Surgery, NOS
A980 Special code for sites such as C420, C421, C423, C424, C760–C768 and C809 (heme, ill-defined, unknown primary). Use item 1294 to show whether surgery was done
- A990 / B990 Unknown if surgery was done; death certificate only
- Rules
Hierarchical: within A000/B000–A790/B790, codes listed later take precedence. Use the 800 and 900 codes only when more precise information is missing.
Cumulative: when a later procedure removes the rest of the primary site, code the total or final result . For example, a lumpectomy, then re-excision, then total mastectomy is coded as the mastectomy . Do not rely on software to accumulate.
Excisional biopsy: an excisional biopsy that removes the entire tumor or leaves only microscopic margins is coded here. A needle biopsy followed by an excision stays a needle biopsy in Surgical Diagnostic and Staging Procedure [1350] (Section 10.1).
Regional tissue is included only if it was removed in continuity with the primary, unless Appendix A says otherwise.
Palliative surgery is also recorded in Palliative Care [3270] .
Breast (C50, 2024+ B-codes)
- Code Procedure
- B200 Partial mastectomy (lumpectomy, segmental, quadrantectomy), after a previous positive biopsy
- B210 Excisional biopsy that diagnosed the cancer, with no pre-operative biopsy proving cancer
- B215 Excisional biopsy for atypia (for example, ADH on core biopsy) that finds cancer
- B240 Re-excision of margins when less than a total mastectomy is done
- B290 Central lumpectomy including the nipple-areolar complex
B300 / B400 / B500 Skin-sparing / nipple-sparing / areolar-sparing mastectomy (x10 without, x20 with removal of the uninvolved contralateral breast)
B600 Total (simple) mastectomy . STORE says to use B600 for a modified radical mastectomy
B700 Radical mastectomy, which removes the pectoralis muscle, with a level I–III axillary dissection. B760 is a bilateral mastectomy for one tumor involving both breasts (for example, bilateral inflammatory carcinoma)
B800 / B900 Mastectomy NOS / surgery NOS
Breast reconstruction is recorded in separate reconstruction items, not in 1291.
Colon (C18, B-codes)
- Code Procedure
- B100 Local tumor destruction (electrocautery, fulguration)
B200–B291 Local excision, including B280 endoscopic polypectomy, B281 endoscopic mucosal resection or dissection, and B291 wide local excision
B300 Partial colectomy : one or more segments but less than half of the colon
B400 Hemicolectomy : the total right or left colon plus part of the transverse colon (including extended hemicolectomy). B401 is subtotal colectomy
- B500 Total colectomy (cecum to the rectosigmoid)
- B600 Total proctocolectomy
- B700 Colectomy with en bloc resection of contiguous organs, NOS
Removing liver metastases during colon surgery is coded in Surgical Procedure/Other Site [1294] , not in 1291.
Scope of Regional Lymph Node Surgery [1292]
- Code Meaning
- 0 None
- 1 Biopsy or aspiration of regional node(s)
- 2 Sentinel lymph node biopsy (SLNB)
- 3 Number of regional nodes removed unknown or not stated; regional node surgery, NOS
- 4 1–3 regional nodes removed
- 5 4 or more regional nodes removed
- 6 SLNB and code 3, 4 or 5 at the same time, or timing not stated
- 7 SLNB and code 3, 4 or 5 at different times
- 9 Unknown or not applicable (for example C420–C424, C589, brain and CNS, C761–C768, C770–C779, C809)
Codes 0–7 are hierarchical and cumulative . A SLNB followed weeks later by a completion dissection is 7 .
The operative report is the primary source for distinguishing SLNB from a dissection. Do not use the number of nodes examined alone. The 4-versus-5 split exists for comparison with historical data and is not a quality judgment.
Distant nodes removed at surgery go in item 1294 .
For breast and melanoma, sentinel node dates and counts are recorded in their own items: Date of Sentinel Lymph Node Biopsy [832], Sentinel Lymph Nodes Examined [834] and Positive [835].
Regional Nodes Examined [830] and Positive [820]
Examined: 00 none; 01–89 exact number; 90 = 90 or more; 95 aspiration only; 96 documented as a sampling, number unknown; 97 documented as a dissection, number unknown; 98 nodes removed, number unknown; 99 unknown.
Positive uses parallel codes. Nodes with only isolated tumor cells are not counted as positive, except for cutaneous melanoma and Merkel cell carcinoma (Section 15.3).
Resolve count discrepancies in this order: final diagnosis, synoptic report, microscopic, gross (Section 10.2).
Surgical Procedure/Other Site [1294]
Codes: 0 none; 1 non-primary surgery, unknown if regional or distant; 2 other regional site; 3 distant lymph node(s) ; 4 distant site ; 5 combination of 2, 3 and 4; 9 unknown.
Code 1 for the special sites (C420–C424, C760–C768, C770–C779, C809) when non-primary surgery was done.
Incidental removal is 0 .
Surgical Margins of the Primary Site [1320]
- Code Meaning
- 0 No residual tumor: all margins grossly and microscopically negative
- 1 Residual tumor, NOS
- 2 Microscopic residual tumor
- 3 Macroscopic (gross) residual tumor
- 7 Margins not evaluable
- 8 No primary site surgery (also for autopsy diagnosis)
- 9 Unknown; no mention of margins; A980 cases; special sites; DCO
Codes 0–3 are hierarchical : if the proximal margin is grossly involved and the distal margin microscopically involved, code 3 .
Record the final margin status after all primary site surgery. For example, a re-excision that clears a positive lumpectomy margin gives 0 .
Reason for No Surgery of Primary Site [1340]
- Code Meaning
- 0 Surgery of the primary site was performed
- 1 Not performed because it was not part of the planned first course
- 2 Contraindicated because of patient risk factors (comorbidities, advanced age, progression)
- 5 Patient died before planned surgery
- 6 Recommended, not performed, no reason documented
- 7 Recommended but refused by the patient, family member or guardian
- 8 Recommended, unknown if performed . Follow it up
- 9 Unknown if recommended or performed; DCO
- Worked examples
A core biopsy shows carcinoma, then a lumpectomy with close but negative margins and a SLNB (2 nodes, both negative): 1291 = B200 , 1292 = 2 , 1320 = 0 , 830 = 02, 820 = 00, 1350 = 02.
An endoscopic polypectomy shows carcinoma with a positive margin, followed by a laparoscopic sigmoidectomy with 16 nodes removed: 1291 = B300 (cumulative, final result), 1292 = 5 , 830 = 16.
A patient with lung cancer and severe COPD is judged too frail for resection and receives SBRT: 1340 = 2 , and 1291 = B000.
Loading diagram... Where does the procedure go?